Idorsia Competitors and Similar CompaniesClear all

Idorsia's competitors and similar companies include Pfizer, Roche, Regeneron Pharmaceuticals, Roivant Sciences and Biocon.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Roche
Roche
Roche Holding is a biotech company that provides in-vitro diagnostics and supplies solutions across various disease areas.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Roivant Sciences
Roivant Sciences
Roivant Sciences is a company that develops and commercializes medicines.
Biocon
Biocon
Biocon is a global biopharmaceutical company.
Founding Date
Founding Date
2017
Founding Date
1849
Founding Date
1896
Founding Date
1988
Founding Date
2014
Founding Date
1978
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Bentley, AU
Footscray, AU
Mulgrave, AU
Sydney, AU
see more
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Dhaka, BD
see more
Locations
Tarrytown, US HQ
Mississauga, CA
München, DE
Bengaluru, IN
Dublin, IE
Limerick, IE
Tokyo, JP
see more
Locations
London, GB HQ
Basel, CH
Boston, US
New York, US
Locations
Bengaluru, IN HQ
Bengaluru, IN
Hyderabad, IN
Visakhapatnam, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
see more
Employees
Employees
8007% increase
Employees
83,0005% increase
Employees
103,605
Employees
12,2563% increase
Employees
904
Employees
16,545
Valuation ($)
Valuation ($)
N/A
Valuation ($)
163.3 b
Valuation ($)
N/A
Valuation ($)
108.2 b
Valuation ($)
9.3 b
Valuation ($)
N/A
Twitter followers
Twitter followers
2.1 k
Twitter followers
491.8 k
Twitter followers
247.2 k
Twitter followers
32.5 k
Twitter followers
1.8 k
Twitter followers
21.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
33
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
16
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.3
Average likes per tweet (last 30 days)
63.4
Average likes per tweet (last 30 days)
9.8
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
4.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
84.85%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
CHF97.1m (FY, 2022)
Revenue (est.)
$58.5b (FY, 2023)
Revenue (est.)
CHF58.7b (FY, 2023)
Revenue (est.)
$13.1b (FY, 2023)
Revenue (est.)
$61.3m (FY, 2023)
Revenue (est.)
₹109.3b (FY, 2023)
Cost of goods
Cost of goods
CHF6.3m (FY, 2022)
Cost of goods
$25b (FY, 2023)
Cost of goods
CHF12.4b (FY, 2023)
Cost of goods
N/A
Cost of goods
$131.3m (FY, 2023)
Cost of goods
₹39.3b (FY, 2023)
Gross profit
Gross profit
CHF90.8m (FY, 2022)
Gross profit
$33.5b (FY, 2023)
Gross profit
CHF48.5b (FY, 2023)
Gross profit
N/A
Gross profit
($70m) (FY, 2023)
Gross profit
₹78.5b (FY, 2023)
Net income
Net income
(CHF827.9m) (FY, 2022)
Net income
$2.2b (FY, 2023)
Net income
CHF12.4b (FY, 2023)
Net income
$4b (FY, 2023)
Net income
($1.1b) (FY, 2023)
Net income
₹6.4b (FY, 2023)

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
27 (FY, 2021)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
4 (Q2, 2021)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
25 (FY, 2021)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
5 (Q2, 2021)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
27 (FY, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (Q2, 2021)
Phase III Trials Products
N/A
Registration Phase Products
Registration Phase Products
N/A
Registration Phase Products
10 (FY, 2021)
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
1 (Q2, 2021)
Registration Phase Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 7.8b
Total funding raised
$ 53.9m
Total funding raised
$ 1.9b
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Pfizer
HQ
New York, US
Employees
83,000↑ 5% increase

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company
Roche
HQ
Basel, CH
Employees
103,605

Roche Holding is a biotech company that provides in-vitro diagnostics and supplies solutions across various disease areas.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
12,256↑ 3% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.

View company
Roivant Sciences
HQ
London, GB
Employees
904

Roivant Sciences is a company that develops and commercializes medicines.

View company